Cargando…
Effects of β-blockers on all-cause mortality in patients with diabetes and coronary heart disease: A systematic review and meta-analysis
Beta-blockers have been considered as an effective treatment in secondary prevention of coronary heart disease (CHD). However, there is still disputed whether β-blockers can increase all-cause mortality in patients with coronary heart disease and diabetes mellitus (DM). Here, our systematic review a...
Autores principales: | Chen, Shiqi, Tian, Panhui, Estau, Dannya, Li, Zijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911879/ https://www.ncbi.nlm.nih.gov/pubmed/36776555 http://dx.doi.org/10.3389/fcell.2023.1076107 |
Ejemplares similares
-
Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017) -
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids
por: Di Fonte, Roberta, et al.
Publicado: (2023) -
A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
por: Huang, Qian, et al.
Publicado: (2020) -
Adjuvanticity of β -Glucan for Vaccine Against Trichinella spiralis
por: Liu, Yi, et al.
Publicado: (2021) -
The Role of Transcription Factor 21 in Epicardial Cell Differentiation and the Development of Coronary Heart Disease
por: Hu, Haochang, et al.
Publicado: (2020)